Medicine shortages in Spain
Live register of drug shortage notices in Spain, aggregated daily from official regulator publications and linked back to every source.
Regulators list each strength and pack separately, so one medicine can carry several notices — compare official per-medicine tallies against “Medicines affected”. How we count
Latest shortage notices in Spain
| Medicine | Status | Severity | Since | Source |
|---|---|---|---|---|
| Quetiapina Cinfa | active | medium | 29 Oct 2026 | AEMPS |
| Axitinibum | active | medium | 29 Oct 2026 | AEMPS |
| Binocrit | active | medium | 29 Oct 2026 | AEMPS |
| Capecitabina | active | medium | 29 Oct 2026 | AEMPS |
| Carboximaltosa Ferrica Sandoz | active |
Official sources for Spain
- Spain Nomenclátor de facturación (SNS) (NOMEN-ES) — official register · last checked 25 Jun 2026
- Agencia Española de Medicamentos y Productos Sanitarios — Suministro (AEMPS) — official register · last checked 1 Nov 2026
Frequently asked questions
How many medicines are in shortage in Spain?
Spain currently has 1447 active medicine shortage notices. Figures update daily from official regulator publications.
Who reports medicine shortages in Spain?
Official shortage notices for Spain are published by Spain Nomenclátor de facturación (SNS) (NOMEN-ES), Agencia Española de Medicamentos y Productos Sanitarios — Suministro (AEMPS). Mederti checks these sources daily and links every notice back to the original publication.
How current is this Spain shortage data?
Mederti scrapes Spain's official shortage register daily. Each notice carries the regulator's own dates; the list on this page reflects the most recent successful update.
Track Spain shortages that matter to you
Watchlists, email alerts, alternatives and cross-country comparison — free for individual pharmacists and clinicians.
Create a free accountData is aggregated from official sources and provided for information only. Mederti is not affiliated with or endorsed by any regulator. Verify with NOMEN-ES before clinical or procurement decisions.